Patients looking for a non-stimulant, metabolic approach to weight loss
Olympia Pharmaceuticals 503B Outsourcing Facility 6700 Conroy Windermere Road, Suite 155 Orlando, FL 32835 Partell Pharmacy: 5835 South Eastern Ave, Ste 101, Las Vegas, NV 89119
GLP-1 serves as both a peptide hormone and a growth factor, is released upon nutrient intake, and promotes insulin secretion stimulated by glucose levels
When this hormone binds to receptors in the brain, pancreas, stomach, and elsewhere, several things happen: Appetite is significantly reduced, with many patients reporting a dramatic decrease in food cravings Gastric emptying slows, meaning food stays in the stomach longer and fullness is sustained after smaller meals Blood sugar regulation improves, reducing the energy spikes and dips that typically drive overeating Interest in high-calorie and highly processed foods often reduces, an effect many patients describe as the food noise quietening Mounjaro (tirzepatide) adds a second mechanism by also activating the GIP receptor
This pre-specified analysis of pooled data from the two trials investigated whether the effects of semaglutide vs